hsa-miR-27a-3p

ncRNA information

ncRNA name

hsa-miR-27a-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

NF1

Cancer information

Cancer name

Glioma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Temozolomide

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level

Tissue resource

paraffin-embedded glioma tissues

Experiment

None


Institute

Beijing Tiantan Hospital

Country

China

Continent

Asia